| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,292 | 3,774 | 4,101 | 7,058 | | Cost of Revenue |
-
|
-
|
-
| 14,080 | | | Gross Profit | 3,292 | 3,774 | 4,101 | (7,022) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,959 | 4,856 | 5,248 | (9,704) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 136 | 138 | 140 | 3,667 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,803) | (1,220) | (1,287) | (984) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 210 | 996 | 226 | (1,033) | | Earnings Before Interest And Taxes | (1,593) | (224) | (1,061) | (1,163) | | Interest Expense |
-
|
-
|
-
| 617 | | Income Before Tax | (1,593) | (224) | (1,061) | (1,780) | | Income Tax Expense | 10 |
-
|
-
| (854) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,603) | (224) | (1,061) | (1,780) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,603) | (224) | (1,061) | (1,780) | | Preferred Stock And Other Adjustments | (135) | (142) | (131) | (555) | | | Net Income Applicable To Common Shares | ($1,738) | ($366) | ($1,191) | ($2,336) |
|
0.51% Nasdaq 
Income Statement
